This announcement is a separate document:
上海荣正企业咨询服务（集团）股份有限公司关于奥精医疗科技股份有限公司2023年限制性股票激励计划首次授予部分第一个归属期符合归属条件之独立财务顾问报告
Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. independent financial advisory report on how Aojing Medical Technology Co., Ltd. granted part of the 2023 restricted stock incentive plan for the first time to meet the requirements for ownership during the first vesting period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.